Get the Stockscreener App
1.465
2.45%
0.035
Geron Corp stock is traded at $1.465, with a volume of 4.42M.
It is up +2.45% in the last 24 hours and up +14.45% over the past month.
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
See More
Previous Close:
$1.43
Open:
$1.41
24h Volume:
4.42M
Relative Volume:
0.41
Market Cap:
$934.70M
Revenue:
$29.48M
Net Income/Loss:
$-201.19M
P/E Ratio:
-4.5781
EPS:
-0.32
Net Cash Flow:
$-216.50M
1W Performance:
+1.03%
1M Performance:
+14.45%
6M Performance:
-43.00%
1Y Performance:
-67.30%
1-Day Range:
$1.41
$1.49
1-Week Range:
$1.37
$1.55
52-Week Range:
$1.09
$4.825
Geron Corp Stock (GERN) Company Profile
Name
Geron Corp
Sector
Industry
Phone
(650) 473-7700
Address
919 EAST HILLSDALE BOULEVARD, FOSTER CITY, CA
Compare GERN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GERN
Geron Corp
|
1.465 | 918.74M | 29.48M | -201.19M | -216.50M | -0.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.60 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
586.35 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.44 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.85 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
314.00 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Geron Corp Stock (GERN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Resumed | Goldman | Sell |
| May-08-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Feb-27-25 | Downgrade | B. Riley Securities | Buy → Neutral |
| Feb-26-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Nov-05-24 | Initiated | H.C. Wainwright | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-09-24 | Initiated | Leerink Partners | Outperform |
| Apr-30-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-29-24 | Initiated | TD Cowen | Buy |
| Mar-15-24 | Reiterated | Needham | Buy |
| Sep-12-23 | Upgrade | Goldman | Neutral → Buy |
| Mar-28-23 | Initiated | Goldman | Neutral |
| Oct-28-22 | Initiated | Wedbush | Outperform |
| Jul-28-22 | Resumed | B. Riley Securities | Buy |
| Nov-02-21 | Initiated | Robert W. Baird | Outperform |
| Feb-18-21 | Resumed | B. Riley Securities | Buy |
| Aug-03-20 | Initiated | Stifel | Buy |
| Nov-19-19 | Resumed | B. Riley FBR | Buy |
| Sep-03-19 | Initiated | H.C. Wainwright | Buy |
| Aug-15-19 | Initiated | Cantor Fitzgerald | Overweight |
| Apr-09-19 | Upgrade | Needham | Hold → Buy |
| Jan-31-19 | Upgrade | B. Riley FBR | Neutral → Buy |
| Oct-02-18 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jul-05-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Sep-13-16 | Reiterated | FBR & Co. | Outperform |
| Sep-13-16 | Reiterated | FBR Capital | Outperform |
| Dec-07-15 | Reiterated | Piper Jaffray | Overweight |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Jun-12-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-12-14 | Downgrade | MLV & Co | Buy → Hold |
| Dec-10-13 | Reiterated | MLV & Co | Buy |
| Dec-10-13 | Upgrade | Needham | Hold → Buy |
| Nov-08-13 | Reiterated | MLV & Co | Buy |
| Oct-16-13 | Initiated | MLV & Co | Buy |
| Aug-30-12 | Initiated | Stifel Nicolaus | Buy |
| Jun-28-12 | Initiated | Needham | Hold |
View All
Geron Corp Stock (GERN) Latest News
Will Breakout in Geron Corporation Sustain Through Next Week2025 Analyst Calls & Consistent Profit Focused Trading Strategies - beatles.ru
SpyGlass Pharma Appoints Elizabeth O’Farrell to its Board of Directors - GlobeNewswire Inc.
Fibonacci Levels Suggest Recovery for Geron Corporation2025 Volume Leaders & Expert Approved Momentum Trade Ideas - beatles.ru
Geron Corporation (GERN) Announces Grant of Stock Options; Scotiabank Reiterates ‘Hold’ Rating - Yahoo Finance
Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron Corporation Names Harout Semerjian as New CEO to Lead Commercialization of RYTELO - Yahoo Finance
Will Geron Corporation stock go up soon2025 Risk Factors & Daily Chart Pattern Signals - Newser
Best data tools to analyze Geron Corporation stockForecast Cut & Expert Curated Trade Setup Alerts - Newser
What data driven models say about Geron Corporation’s futureMarket Sentiment Report & AI Forecast Swing Trade Picks - Newser
Visual analytics tools that track Geron Corporation performanceQuarterly Market Review & Community Supported Trade Ideas - Newser
Visual trend scoring systems applied to Geron CorporationForecast Cut & Capital Efficient Trade Techniques - Newser
How high can Geron Corporation stock price go in 2025 - Newser
Real time social sentiment graph for Geron CorporationEarnings Risk Summary & Real-Time Volume Spike Alerts - Newser
Q3 Earnings Forecast for Geron Issued By Leerink Partnrs - Defense World
Geron Corporation’s SWOT analysis: biotech stock faces growth hurdles amid positive outlook - Investing.com
Geron Corporation Surges: CEO Appointment and Q2 Triumph - StocksToTrade
News impact scoring models applied to Geron Corporation2025 Pullback Review & Free Verified High Yield Trade Plans - Newser
Geron Corporation Breaks Below Key Support LevelQuarterly Portfolio Report & Fast Exit/Entry Strategy Plans - 선데이타임즈
Geron Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Leerink Partnrs Issues Positive Estimate for Geron Earnings - Defense World
Is Geron Corporation Forming a Bottom PatternLong Hold Safe Return Strategy Reviewed - beatles.ru
Q1 Earnings Forecast for Geron Issued By Wedbush - Defense World
Geron's Positive Momentum and Strategic Leadership Drive Buy Rating Amid Rytelo Demand Growth. - AInvest
Geron Corporation (NASDAQ:GERN) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Geron Corporation shares rise 1.56% after-hours after granting 11,000,000 stock options to new CEO. - AInvest
Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
Geron: I Think We've Seen This Movie Before (NASDAQ:GERN) - Seeking Alpha
A Quick Look at Today's Ratings for Geron(GERN.US), With a Forecast Between $4 to $5 - 富途牛牛
Geron 2025 Q2 Earnings Beats Expectations with 80% EPS Improvement - AInvest
Geron Corporation (NASDAQ:GERN) Q2 2025 Earnings Call Transcript - Insider Monkey
Geron: Q2 Earnings Snapshot - Huron Daily Tribune
Geron Corp (GERN) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Geron (GERN) Q2 Revenue Jumps 5,477% - sharewise.com
Semerjian to lead Geron - BioCentury
Geron reports Q2 EPS (2c), consensus (3c) - TipRanks
Geron Corporation Set to Release Q2 Financial Results, Eyes Market Reaction - StocksToTrade
Earnings call transcript: Geron surpasses Q2 2025 forecasts, stock rises By Investing.com - Investing.com South Africa
Earnings call transcript: Geron surpasses Q2 2025 forecasts, stock rises - Investing.com
Geron appoints Harout Semerjian as CEO - TipRanks
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Geron Q2 2025 presentation: RYTELO sales climb 24%, stock jumps premarket - Investing.com
Geron earnings beat, revenue topped estimates By Investing.com - Investing.com Canada
Geron earnings beat, revenue topped estimates - Investing.com
Geron appoints Harout Semerjian as new CEO amid RYTELO expansion - Investing.com
Geron Corporation Reports Second Quarter 2025 Financial Results and Recent Business Highlights - Yahoo Finance
Geron Taps Former Novartis Hematology Leader as CEO: 30-Year Expert to Scale RYTELO Commercial Launch - Stock Titan
Universal Beteiligungs und Servicegesellschaft mbH Purchases New Holdings in Geron Corporation (NASDAQ:GERN) - Defense World
What is the dividend policy of Geron Corporation stockUnlock daily trading alerts for profits - Jammu Links News
What makes Geron Corporation stock price move sharplyExtraordinary earning power - Jammu Links News
Ball Corp Set to Report Q2 Earnings: What Lies Ahead for the Stock? - The Globe and Mail
Leerink Partners Reiterates a Buy Rating on Geron Corporation (GERN) With a $3 PT - Insider Monkey
Geron Corp Stock (GERN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Geron Corp Stock (GERN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Samuels Scott Alan | EVP, Chief Legal Officer |
Feb 27 '25 |
Buy |
1.61 |
15,000 |
24,150 |
26,682 |
| SCARLETT JOHN A | Chairman, President and CEO |
Feb 27 '25 |
Buy |
1.76 |
12,500 |
22,062 |
12,500 |
| Ziegler James | EVP, Chief Commercial Officer |
Feb 27 '25 |
Buy |
1.60 |
100,000 |
160,000 |
100,000 |
0.82%
1.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):